Cochrane Database of Systematic Reviews 2012
DOI: 10.1002/14651858.cd010110
|View full text |Cite
|
Sign up to set email alerts
|

Neostigmine for reversal of neuromuscular block in paediatric patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Other contributors to the effect of lower dosage of neostigmine in pediatric patients include the local differences at the neuromuscular junction in children (eg, the number and quantity of nicotinic receptors, amount of acetylcholine reserve, or acetylcholinesterase enzyme activity), a more rapid circulation time and the increased cardiac output speeding the delivery of these agents to the neuromuscular junction and the onset of effect, and more rapid removal of NMBDs from the neuromuscular junction 38,94,95. Up till now, there have not been enough sound evidence for confirming both the efficacy and safety of appropriate use of neostigmine to reverse neuromuscular block in pediatric patients, and further studies with more coherent design and measurements are needed 96…”
Section: Neostigmine For Special Patientsmentioning
confidence: 99%
“…Other contributors to the effect of lower dosage of neostigmine in pediatric patients include the local differences at the neuromuscular junction in children (eg, the number and quantity of nicotinic receptors, amount of acetylcholine reserve, or acetylcholinesterase enzyme activity), a more rapid circulation time and the increased cardiac output speeding the delivery of these agents to the neuromuscular junction and the onset of effect, and more rapid removal of NMBDs from the neuromuscular junction 38,94,95. Up till now, there have not been enough sound evidence for confirming both the efficacy and safety of appropriate use of neostigmine to reverse neuromuscular block in pediatric patients, and further studies with more coherent design and measurements are needed 96…”
Section: Neostigmine For Special Patientsmentioning
confidence: 99%
“…These drugs if used alone are associated with certain untoward effects such as increased secretions and mucus resulting in elevated airway resistance, vomiting, diarrhea, and decreased heart rate. [2][3][4] To counter these undesirable effects, anticholinergic agents atropine and glycopyrrolate are often used in conjunction with neostigmine.…”
Section: Introductionmentioning
confidence: 99%
“…Standard tests such as sustained head lift, hand‐grip strength, and leg lift are not possible in children, and neuromuscular monitoring is not routinely used. Furthermore, the use of neostigmine is associated with postoperative nausea, vomiting, increased salivation, and bradycardia; the dose of neostigmine should be limited to 0.06 to 0.08 mg/kg, as additional doses produce no further reversal of NMB …”
mentioning
confidence: 99%